Heather du Plessis-Allan DriveOkava has been investigating the use of GLP-1 receptors in cats and found it has similar effects to weight-loss drugs on humans.
The San Francisco-based company is hoping to develop a long-acting implant as opposed to regular injections.
But, Healthy Pets New Zealand trustee and vet Dr Cath Watson says weight loss drugs should not be the first option for pets.
Watson told Andrew Dickens that pet obesity levels are "pretty bad and getting worse".
LISTEN ABOVE
In 1 playlist(s)
Heather du Plessis-Allan Drive
With a straight down the middle approach, Heather du Plessis-Allan Drive on Newstalk ZB delivers the…Social links
Follow podcast
Recent clips
Gavin Grey: UK correspondent on UK prisoners reoffending after early prison release
03:57
Shane Solly: Harbour Asset Management expert on what a drop in business confidence could mean for the OCR
03:33
Jonathan Waecker: Michael Hill CEO on the company's profit jumping 376 percent to A$10m
03:20